Laura Sneed
Medical · Pasadena, CANPI 1629238167
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 259 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations.
Across 259 payments — averaging $21.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Neurelis, Inc.$712
- SK Life Science, Inc.$641
- Corium, LLC$409
- Jazz Pharmaceuticals Inc.$305
- AbbVie$285
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,46599%
- Education$281%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 48 | $1,196 |
| Neurelis, Inc. | 24 | $712 |
| SK Life Science, Inc. | 48 | $641 |
| Corium, LLC | 23 | $409 |
| Jazz Pharmaceuticals Inc. | 11 | $305 |
| AbbVie | 11 | $285 |
| Acadia Pharmaceuticals Inc | 8 | $230 |
| Aquestive Therapeutics, Inc. | 8 | $176 |
| Pfizer | 7 | $172 |
| Supernus Pharmaceuticals, Inc. | 9 | $169 |
| Immedica Pharma US, Inc. | 7 | $162 |
| Sumitomo Pharma America, Inc. | 7 | $161 |
| Greenwich Biosciences, Inc. | 10 | $121 |
| Lilly USA, LLC | 5 | $108 |
| Aucta Pharmaceuticals, Inc. | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 2 | $59 |
| Cranial Technologies, Inc | 3 | $54 |
| Eisai Inc. | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Travere Therapeutics, Inc. | 4 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $34 |
| Biomarin Pharmaceutical Inc. | 2 | $34 |
| Adlon Therapeutics L.p. | 2 | $30 |
| Intrabio Inc | 1 | $26 |
| Biogen | 1 | $25 |
| Sarepta Therapeutics, Inc. | 1 | $23 |
| Livanova USA, Inc. | 1 | $23 |
| Argenx US, Inc. | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$146
How this compares
$5,493 in reported general payments places this provider in the 85th percentile of 2,087 medical providers in California.
Other medical in Pasadena
- Jamie CordobaPasadena$16K
- Nicola LowreyOrange$655K
- Justin LoveLoma Linda$553K
- Alison GracomIrvine$467K
- Jeffrey BonnaudLos Angeles$314K
- Ana TorresLaguna Beach$229K
- Heather ParlettRedlands$168K
- David DoriguzziLancaster$166K
- Deirdre MoxleyFullerton$149K
- Linda RankLadera Ranch$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.